Effects of intravenous human albumin, enteral cilostazol, and combination therapy on the reduction of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage - Top-Institutions - MDSpire

Effects of intravenous human albumin, enteral cilostazol, and combination therapy on the reduction of delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage

  • By

  • Adnan I. Qureshi

  • Hassan Raza

  • Jonathan Beall

  • Byron Gajewski

  • Renee H. Martin

  • Jose I. Suarez

  • July 16, 2026

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    American Heart Association/American Stroke Association
    American Heart Association/American Stroke Association

    Dallas, Texas

    Key Differentiators

    • Neurology
  • #2

    Neurocritical Care Society
    Neurocritical Care Society

    Schaumburg, Illinois

    Key Differentiators

    • Neurology
  • #3

    European Stroke Organization
    European Stroke Organization

    Brussels, Belgium

    Key Differentiators

    • Neurology
  • #4

    National Institute of Neurological Disorders and Stroke
    National Institute of Neurological Disorders and Stroke

    Bethesda, Maryland

    Key Differentiators

    • Neurology
  • #5

    Albumin in Subarachnoid Hemorrhage (ALISAH)
    Albumin in Subarachnoid Hemorrhage (ALISAH)

    N/A, N/A

    Key Differentiators

    • Neurology

Original Source(s)

Related Content